{
  "actions": [
    {
      "acted_at": "2023-06-22",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2023-06-22",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s2157-118",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "118",
  "cosponsors": [
    {
      "bioguide_id": "R000595",
      "district": null,
      "name": "Rubio, Marco",
      "original_cosponsor": true,
      "sponsored_at": "2023-06-22",
      "state": "FL",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2023-06-22",
  "number": "2157",
  "official_title": "A bill to repeal prescription drug price control provisions of the Inflation Reduction Act.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Protect Drug Innovation Act",
  "sponsor": {
    "bioguide_id": "L000577",
    "district": null,
    "name": "Lee, Mike",
    "state": "UT",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2023-06-22",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2023-06-22",
    "date": "2024-07-19T20:52:32Z",
    "text": "Protect Drug Innovation Act\n\nThis bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Protect Drug Innovation Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Protect Drug Innovation Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to repeal prescription drug price control provisions of the Inflation Reduction Act.",
      "type": "official"
    }
  ],
  "updated_at": "2024-07-24T15:21:28Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/s/BILLSTATUS-118s2157.xml"
}